WisdomTree BioRevolution Fund (WDNA)

Assets	$4.52M
Expense Ratio	0.45%
PE Ratio	29.17
Forward PE	17.99
Shares Out	200,000
Dividend	$0.77 (3.32%)
Ex-Dividend Date	Dec 26, 2025
Payout Frequency	Annual
Payout Ratio	70.21%

Volume	413
Open	23.29
Previous Close	22.80
Day's Range	23.21 - 23.29
52-Week Low	15.67
52-Week High	24.74
Beta	0.99
Holdings	87
Inception Date	Jun 3, 2021

About WDNA

Fund Home Page

The WisdomTree BioRevolution Fund (WDNA) is an exchange-traded fund that is based on the WisdomTree BioRevolution index. The fund tracks a modified equally-weighted index of companies in developed markets that focus on the advancements in genetics and biotechnology. WDNA was launched on Jun 3, 2021 and is issued by WisdomTree.

• Asset Class: Equity
• Category: Health
• Stock Exchange: Cboe BZX
• Ticker Symbol: WDNA
• ETF Provider: WisdomTree
• Index Tracked: WisdomTree BioRevolution Index

Top 10 Holdings

41.89% of assets

Name	Symbol	Weight
Moderna, Inc.	MRNA	12.26%
Twist Bioscience Corporation	TWST	7.83%
Eli Lilly and Company	LLY	3.74%
10x Genomics, Inc.	TXG	3.15%
Natera, Inc.	NTRA	3.10%
Johnson & Johnson	JNJ	2.70%
Tempus AI, Inc.	TEM	2.46%
Iovance Biotherapeutics, Inc.	IOVA	2.41%
United Therapeutics Corporation	UTHR	2.21%
Darling Ingredients Inc.	DAR	2.02%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 26, 2025	$0.77052	Dec 30, 2025
Dec 26, 2024	$0.1071	Dec 30, 2024
Dec 22, 2023	$0.135	Dec 28, 2023
Dec 23, 2022	$0.06526	Dec 29, 2022
Dec 27, 2021	$0.02458	Dec 30, 2021

Performance

WDNA had a total return of 41.76% in the past year, including dividends. Since the fund's inception, the average annual return has been -0.11%.

Data Sources: S&P Global Market Intelligence, CBOE, and more

Historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP. Several fund data points are also provided by Finnhub.

Last checked:

Oct 16, 2026

Data Sources Report a data error